. 2015 Apr 19;21:1107–1114. doi: 10.12659/MSM.893180

Table 1.

Biochemical parameters for liver and kidney tissues in control and treated groups.

Tissue	Group	TAS	TOS	TNF-α	IL-1β	IL-6
Liver	Control	1.13±0.10	185.28±52.32	488.10±141.37	759.92±113.43	713.74±52.90^a
	DLM	0.39±0.18^a	344.46±24.82^a	2554.38±251.19^a	1067.53±454.50^b	1527.46±650.45^b
	GLN	1.01±0.20^b	197.95±37.22^b	743.79±292.06^a,^b	611.28±46.53^c	708.99±54.09^b
	DLM+GLN	0.86±0.12^a	225.67±19.53	1398.17±249.63^a,^b,^c	958.11±74.88	1043.56±118.33
Kidney	Control	2.01±0.23	23.97±3.43	489.74±374.62	759.68±87.53^a	672.01±121.34
	DLM	1.48±0.12^a	68.13±6.50^a	1223.51±248.06^a	1067.53±454.50	1280.30±103.1^a
	GLN	1.74±0.59	16.84±4.03^a,^b	439.73±285.41^b	611.28±46.53^b	753.92±85.79^b
	DLM+GLN	1.51±0.38	29.64±11.71^b,^c	770.40±133.50^b	958.11±74.88^a ^c	694.37±48.72^b

TAS – total antioxidant capacity (μmol H₂O₂ equivalent/L); TOS – total oxidant capacity (mmol Trolox equivalent/L); TNF-α – tumor necrosis factor-alpha (pg/mL); IL-1β – interleukin-1 beta (pg/mL); IL-6 – interleukin-6 (pg/mL); results are expressed as mean ±SD.

The result is significant when compared to Control group;

the result is significant when compared to DLM group;

the result is significant when compared to GLN group.